Why an ovary disorder may get a new name: Men can have it, too
But what about men? If PCOS is a metabolic disease, could men be affected by it as well? Yıldız believes so. “The metabolic derangements that are observed in women with PCOS are not unique to women,” he said. “They are also observed in men.”
Indeed, a 2022 study published in the journal Endocrine Reviews found that men with PCOS-like symptoms had a higher prevalence of type 2 diabetes, obesity, and cardiovascular disease compared to men without these symptoms. While these men didn’t have ovaries, they did have metabolic disturbances similar to those seen in women with PCOS. This suggests that PCOS may not be just a condition of the ovaries, but rather a metabolic disorder that can affect both men and women.
So, what does this mean for men like Al Barrus who may be experiencing PCOS-like symptoms? It suggests that they may not be alone. While the medical community has long focused on PCOS as a condition that primarily affects women, there is growing recognition that men can also be affected by similar metabolic disturbances. This shift in understanding could lead to better diagnosis and treatment for men with PCOS-like symptoms.
As for Barrus, he plans to continue advocating for greater recognition of a male form of PCOS. “Just because I don’t have ovaries doesn’t mean I can’t experience similar symptoms and health challenges as my sisters,” he said. “It’s time for the medical community to start looking at PCOS as a metabolic disorder that can affect anyone, regardless of gender.”
With ongoing research and advocacy efforts, it’s possible that a more inclusive understanding of PCOS will emerge, one that recognizes the condition as a metabolic disorder that can affect both men and women. And for men like Al Barrus, who have long felt overlooked in discussions of PCOS, this shift in perspective could bring about much-needed validation and support.
But changing the name of a disorder like PCOS is not just about semantics. It reflects a broader shift in understanding and approach to the condition. The metabolic aspect of PCOS has long been overlooked, but as research continues to show its significance, it is becoming increasingly clear that PCOS is more than just a reproductive disorder.
The metabolic component of PCOS is crucial, not just for women with the syndrome, but also for their family members, including men. Studies have shown that metabolic disorders, such as prediabetes and insulin resistance, are prevalent in families of women with PCOS. This has led to recommendations for screening fathers and brothers of patients with PCOS for metabolic disorders.
The idea of PCOS as a metabolic disease is gaining traction, with researchers like Bulent Yıldız and Zhu leading the way in identifying genetic markers associated with PCOS and related metabolic conditions in men. This research has the potential to open up new avenues for intervention and treatment for a broader population at risk of PCOS.
However, there are concerns about shifting the focus away from women, who are the primary sufferers of PCOS. Helena Teede, a professor of women’s health, cautions against sidelining women’s health concerns in favor of exploring a potential metabolic subtype in men. PCOS affects one in eight women profoundly, and it is essential to continue prioritizing their health and well-being.
Despite these challenges, the process of renaming PCOS to reflect its metabolic aspects is underway. The secrecy surrounding the renaming process underscores its significance and complexity. Stakeholders, including researchers, clinicians, and patients, are all involved in the decision-making process, which is nearing its final stages.
Changing the name of a disorder like PCOS is not just a matter of semantics; it reflects a fundamental shift in understanding and approach to the condition. By acknowledging the metabolic component of PCOS, researchers and clinicians are paving the way for a more comprehensive and inclusive approach to diagnosis and treatment. They have to wait just like everyone else for the big reveal. “We’re really excited to see what they come up with,” said Harry, “especially considering the effort that went into getting there.”
Once the new name is made public, the next step will be updating SNOMED CT’s terminology database and all the references to the condition. This will involve a significant amount of work, as the condition is mentioned in countless medical records, research studies, and clinical guidelines. However, the team at SNOMED CT is prepared for the challenge and is committed to ensuring a smooth transition to the new name.
Overall, the process of changing a medical term is complex and time-consuming, but it is essential to ensure that medical terminology accurately reflects current medical knowledge and practices. By carefully reviewing and updating terminology, organizations like SNOMED CT play a crucial role in maintaining the integrity and accuracy of medical information worldwide.
As for the future, SNOMED CT will continue to receive requests for changes to medical terminology and will work diligently to evaluate and implement these changes as needed. With a dedicated team of experts and a thorough review process in place, SNOMED CT is well-equipped to handle the evolving landscape of medical terminology and ensure that health terms remain standardized and up-to-date for years to come.
The recent revelation made by Case has sparked curiosity and concern within the health community. The secrecy surrounding the agreement, with the ominous warning of potential consequences for disclosing the name, has left many wondering about the implications of such a statement.
In an exclusive interview with Case, he shared that he was given a vague warning about an agreement that he was not at liberty to disclose. The cryptic message of “we can’t tell you the name, otherwise we’d pretty much have to kill you” has raised eyebrows and speculation about what could be at stake.
The implications of such a statement are unclear, but it has certainly piqued the interest of many in the health sector. What could be so sensitive that it warrants such extreme measures to keep it under wraps? Is it a groundbreaking discovery, a controversial treatment, or something even more sinister?
As we delve deeper into this mysterious agreement, it is important to consider the potential impact it could have on the health and well-being of men and boys. With Rise Together and the Boston Foundation supporting our coverage of health challenges facing this demographic, we are committed to uncovering the truth behind this enigmatic agreement.
Our financial supporters play a crucial role in enabling us to pursue investigative journalism that sheds light on important issues facing men and boys. Their generosity allows us to dig deeper, ask the tough questions, and hold those in power accountable.
As we continue our investigation into this secretive agreement, we will remain vigilant in our pursuit of the truth. Stay tuned for updates on this developing story as we work to unravel the mystery and uncover the potential implications for the health and well-being of men and boys everywhere.
